These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9853978)

  • 41. CSF and serum concentrations of clozapine and its demethyl metabolite: a pilot study.
    Nordin C; Almé B; Bondesson U
    Psychopharmacology (Berl); 1995 Nov; 122(2):104-7. PubMed ID: 8848524
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder.
    Spina E; D'Arrigo C; Migliardi G; Santoro V; Muscatello MR; Micò U; D'Amico G; Perucca E
    Ther Drug Monit; 2006 Oct; 28(5):599-602. PubMed ID: 17038872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacogenomic Variants and Drug Interactions Identified Through the Genetic Analysis of Clozapine Metabolism.
    Pardiñas AF; Nalmpanti M; Pocklington AJ; Legge SE; Medway C; King A; Jansen J; Helthuis M; Zammit S; MacCabe J; Owen MJ; O'Donovan MC; Walters JTR
    Am J Psychiatry; 2019 Jun; 176(6):477-486. PubMed ID: 30922102
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Elucidation of individual cytochrome P450 enzymes involved in the metabolism of clozapine.
    Fang J; Coutts RT; McKenna KF; Baker GB
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Nov; 358(5):592-9. PubMed ID: 9840430
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous determination of clozapine, norclozapine and clozapine-N-oxide in human plasma by high-performance liquid chromatography with ultraviolet detection.
    Liu YY; van Troostwijk LJ; Guchelaar HJ
    Biomed Chromatogr; 2001 Jun; 15(4):280-6. PubMed ID: 11438972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clozapine metabolism rate as a possible index of drug-induced granulocytopenia.
    Mauri MC; Rudelli R; Bravin S; Gianetti S; Giuliani E; Guerrini A; Orlandi R; Invernizzi G
    Psychopharmacology (Berl); 1998 Jun; 137(4):341-4. PubMed ID: 9676893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of brain clozapine and norclozapine concentrations in humans from a scaled pharmacokinetic model for rat brain and plasma pharmacokinetics.
    Li CH; Stratford RE; Velez de Mendizabal N; Cremers TI; Pollock BG; Mulsant BH; Remington G; Bies RR
    J Transl Med; 2014 Aug; 12():203. PubMed ID: 25142323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine.
    Eiermann B; Engel G; Johansson I; Zanger UM; Bertilsson L
    Br J Clin Pharmacol; 1997 Nov; 44(5):439-46. PubMed ID: 9384460
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients.
    Rostami-Hodjegan A; Amin AM; Spencer EP; Lennard MS; Tucker GT; Flanagan RJ
    J Clin Psychopharmacol; 2004 Feb; 24(1):70-8. PubMed ID: 14709950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clozapine: Dose, Sex, Ethnicity, Smoking Habit, Age, Body Weight, and Plasma Clozapine and N -Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice.
    Flanagan RJ; Hunter S; Obee SJ; Reeves S
    J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):131-138. PubMed ID: 36735578
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effectiveness of clozapine in neuroleptic-resistant schizophrenia: clinical response and plasma concentrations.
    Llorca PM; Lancon C; Disdier B; Farisse J; Sapin C; Auquier P
    J Psychiatry Neurosci; 2002 Jan; 27(1):30-7. PubMed ID: 11836974
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term therapeutic drug monitoring of clozapine and metabolites in psychiatric in- and outpatients.
    Dettling M; Sachse C; Brockmöller J; Schley J; Müller-Oerlinghausen B; Pickersgill I; Rolfs A; Schaub RT; Schmider J
    Psychopharmacology (Berl); 2000 Sep; 152(1):80-6. PubMed ID: 11041319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Disposition of clozapine and desmethylclozapine in schizophrenic patients.
    Lin SK; Chang WH; Chung MC; Lam YW; Jann MW
    J Clin Pharmacol; 1994 Apr; 34(4):318-24. PubMed ID: 8006199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma clozapine and norclozapine in patients prescribed different brands of clozapine (Clozaril, Denzapine, and Zaponex).
    Couchman L; Morgan PE; Spencer EP; Johnston A; Flanagan RJ
    Ther Drug Monit; 2010 Oct; 32(5):624-7. PubMed ID: 20720516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Therapeutic drug monitoring of clozapine and norclozapine in human serum using ultra-performance liquid chromatography- tandem mass spectrometry.
    Ming DS; Heathcote J
    J Anal Toxicol; 2009 May; 33(4):198-203. PubMed ID: 19470221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia.
    Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY
    Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of variable cigarette consumption on the interaction with clozapine and olanzapine.
    Haslemo T; Eikeseth PH; Tanum L; Molden E; Refsum H
    Eur J Clin Pharmacol; 2006 Dec; 62(12):1049-53. PubMed ID: 17089108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clozapine and Norclozapine Concentrations in Paired Human Plasma and Serum Samples.
    Sa H; Fisher SS; K S; Rj F
    Ther Drug Monit; 2018 Feb; 40(1):148-150. PubMed ID: 29240616
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retrospective evaluation of therapeutic drug monitoring of clozapine and norclozapine in Belgium using a multidrug UHPLC-MS/MS method.
    Patteet L; Maudens KE; Vermeulen Z; Dockx G; De Doncker M; Morrens M; Sabbe B; Neels H
    Clin Biochem; 2014 Dec; 47(18):336-9. PubMed ID: 25289972
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Higher plasma drug concentration in clozapine-treated schizophrenic patients with side effects of obsessive/compulsive symptoms.
    Lin SK; Su SF; Pan CH
    Ther Drug Monit; 2006 Jun; 28(3):303-7. PubMed ID: 16778711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.